Asia Pacific Bone Cement Market Report and Forecast 2024-2032

Asia Pacific Bone Cement Market Report and Forecast 2024-2032

Market Outlook

According to the report the Asia Pacific bone cement market grew significantly in 2022. Aided by the escalating orthopaedic surgeries and a burgeoning aging populace across major nations, the market is projected to further grow at a CAGR of 6.6% between 2024 and 2032 to reach a value of about USD 350 million by 2032.

Bone cement has cemented its place in the medical realm, particularly in orthopaedic surgeries. Essentially a filler, it's employed to bridge the space between an implant and the bone. Predominantly, its application is profound in arthroplasty, especially knee and hip replacement surgeries. Its adhesive property guarantees a robust connection, promising durability and post-operative movement fluidity.

One of the primary accelerators for the Asia Pacific bone cement market growth is the increasing prevalence of bone-related maladies such as osteoporosis and osteoarthritis. With nations like Japan and China hosting a sizable senior population, the frequency of orthopaedic issues has surged, thus intensifying the demand for bone cement owing to its pivotal role in joint replacement surgeries.

Furthermore, the region's keenness towards sports and physical activities, while contributing to physical wellness, has occasionally resulted in sports-induced injuries. This inadvertently has pushed the demand for surgical interventions, where bone cement is paramount to ensure longevity and success of the procedures.

Medical strides in the Asia Pacific region, particularly in minimally invasive surgeries (MIS), have further influenced the Asia Pacific bone cement market outlook. MIS, celebrated for reduced hospital stays and minimised post-operative discomfort, often leans on bone cement to ensure impeccable results.

The dental arena in the Asia Pacific is another sector witnessing a surge in bone cement application. With aesthetic dentistry garnering traction, bone cement's role in procedures like dental implants has become indispensable, broadening the market spectrum.

The healthcare fabric of the Asia Pacific is undergoing rapid transformation. With nations ramping up their healthcare investments and research capabilities, the bone cement market stands to gain considerably. For instance, groundbreaking research from the region has birthed next-gen bone cements with amplified biocompatibility and reduced setting time. These innovations not only uplift the patient experience but also help amplify the Asia Pacific bone cement market demand.

Outside the confines of healthcare, academic circles in the Asia Pacific region are delving into the diverse potentialities of bone cement. Preliminary research suggests potential applications in areas like construction, although in its nascence, hinting at a broader horizon for bone cement in the near future.

Market Segmentation

The market can be divided based on product, application, end use, and country.

Market Breakup by Product

• Calcium Phosphate Cement (CPC)
• Glass Polyalkenoate Cement
• Polymethyl Methacrylate (PMMA) Cement

Market Breakup by Application

• Kyphoplasty
• Arthroplasty
• Vertebroplasty

Market Breakup by End Use

• Hospital
• Ambulatory Surgical Centres
• Clinics

Market Breakup by Country

• China
• Japan
• India
• ASEAN
• South Korea
• Australia
• Others

Competitive Landscape

The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the Asia Pacific bone cement market. Some of the major players explored in the report are as follows:

• Johnson & Johnson MedTech (Depuy Synthes)
• Stryker Corporation
• Zimmer Biomet Holdings, Inc
• Smith & Nephew plc
• Medtronic plc
• Laboratorios SL S.A.
• Heraeus Group
• Teknimed
• Leader Biomedical
• Others